Cofetuzumab

(Synonyms: PF-06523435; hu24)
Customer Review

Based on 1 Customer Validation

Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab is typically CHO (Chinese hamster ovary) cells. Cofetuzumab downregulates PTK7 expression, modulates its downstream signaling pathways, and inhibits tumor sphere formation of ovarian cancer cells. Cofetuzumab can be used to synthesize the ADC molecule Cofetuzumab pelidotin (HY-P99829). Cofetuzumab is applicable to the research of tumors such as ovarian cancer.

For research use only. We do not sell to patients.

  • Purity: 99.31%
  • CAS No.: 1869928-62-0
  • Molecular Weight:146.7 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All ROR Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00